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Abstract
PURPOSE—To report the frequency of optical coherence tomography (OCT) scan artifacts and
compare macular thickness measurements, inter-scan reproducibility and inter-device agreeability
across three spectral / Fourier domain (SD) OCTs (Cirrus HD-OCT, RTVue-100 and Topcon 3D-
OCT 1000) and one time domain (TD) OCT (Stratus OCT).
DESIGN—Prospective, non-comparative, non-interventional case series.
PARTICIPANTS—52 patients seen at New England Eye Center, Tufts Medical Center retina
service between February and August 2008.
METHODS—Two scans were performed for each of the SD-OCT protocols: Cirrus macular cube
512×128, RTVue (E)MM5 and MM6, Topcon 3D macular and radial, in addition to one TD-OCT
scan via Stratus macular thickness protocol. Scans were inspected for six types of OCT scan artifacts
and analyzed. Inter-scan reproducibility and inter-device agreeability were assessed by intraclass
correlation coefficients (ICCs) and Bland-Altman plots, respectively.
MAIN OUTCOME MEASURE—OCT image artifacts, Macular thickness, Reproducibility,
Agreeability.
RESULTS—TD-OCT scans contained a significantly higher percentage of clinically significant
improper central foveal thickness (IFT) post-manual correction (greater than or equal to 11 μm
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change) compared to SD-OCT scans. Cirrus HD-OCT had a significantly lower percentage of
clinically significant IFT (11.1%) compared to the other SD-OCT devices (Topcon 3D: 20.4%,
Topcon Radial: 29.6%, RTVue (E)MM5: 42.6%, RTVue MM6: 24.1%; p= 0.001). All three SD-
OCT had central foveal subfield thicknesses significantly greater than TD-OCT post manual
correction (p< 0.0001). All 3 SD-OCT demonstrated a high degree of reproducibility in the central
foveal region (ICC= 0.92 to 0.97). Bland-Altman plots showed low agreeability between TD- and
SD-OCT scans.
CONCLUSIONS—Cirrus HD-OCT scans exhibited the lowest occurrence of any artifacts (68.5%),
IFT (40.7%) and clinically significant IFT (11.1%) compared to all other OCT devices examined,
while Stratus OCT scans exhibited the highest occurrence of clinically significant IFT compared to
all 3 SD-OCT examined. Significant differences in macular thickness occurred among SD- and TD-
OCT. All SD-OCT examined revealed high reproducibility in the central foveal subfield (ICC 0.92
to 0.97). Higher scan density and speed obtainable with SD-OCT appear to improve reproducibility.
Although software breakdown occurred to a variable degree with different commercial OCT, further
work on improving segmentation algorithm to decrease artifacts is warranted.
Introduction
Optical coherence tomography (OCT)1 is a non-invasive imaging technique clinically utilized
for the visualization of the retina, optic nerve, and anterior segment.2-4 Conventional time
domain OCT employ a mechanically scanning reference arm and sequentially measure the
echo time delays.5 In contrast, the newer generation spectral or Fourier domain OCT use a
stationary reference arm to obtain an interference spectrum, which then undergoes Fourier
transformation to allow for simultaneous measurement of all the echo time delays of light.6 As
a result, this new technology significantly improves the system speed and sensitivity.7-9
Spectral / Fourier domain OCT have an image acquisition speed of 18,000 to 50,000 A-scans
per second, with a maximum of approximately 300,000 A-scans per second10, 11, limited by
signal levels, as compared to time domain maximum of approximately 400 A-scans per second.
The faster imaging time translates into decreased motion artifacts and greater coverage of the
retina. The axial resolution of an OCT device is inversely proportional to the bandwidth of its
light source.12 Standard time domain OCT utilizes a low-coherence superluminescent diode
(SLD) light source at a wavelength of 840 nm and a bandwidth of ∼25 nm, allowing it to
achieve an 8−10 μm axial resolution. In contrast, most commercially available spectral / Fourier
domain OCT devices use an SLD light source with a bandwidth of ∼50 nm, achieving a 5−8
μm axial resolution in tissue. The greater resolving power of these OCT devices translates into
enhanced capabilities to observe fine ocular pathologies.
The current clinical uses of OCT in retina has largely been qualitative, for the visualization of
pathologies such as macular edema13, subretinal fluid14, epiretinal membranes (ERM)15-17,
vitreomacular traction (VMT)18-20, macular holes21, 22, photoreceptor layer and/or retinal
pigment epithelium (RPE) disruption23, and choroidal neovascularization membranes
(CNVM)24, 25. However, it is now possible to acquire large volumes of quantitative data for
OCT analysis with the improved scan density, retinal coverage and image resolution of the
spectral domain OCT. Quantitative OCT analysis is playing an increasingly important clinical
role with the development of anti-VEGF (Vascular Endothelial Growth Factor) therapies for
tracking treatment outcomes in patients with neovascular age-related macular degeneration
(AMD). In these patients, treatment success is defined anatomically as a reduction in intra/sub-
retinal and sub-RPE fluids, which translates into a reduction in thickening of the Early
Treatment Diabetic Retinopathy Study (ETDRS)-like map.26 Retinal thickness is generated by
measuring the distance between the inner retinal border (vitreous/retina interface) and the outer
retinal border (retinal/RPE interface). Then retinal thickness are tracked accurately over time
via generation of OCT enface images and registering various landmarks (i.e. blood vessels)
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onto a fundus image generated at baseline. The reliability of such change analysis depends on
the accuracy of segmentation software. While much progress has been made in improving the
accuracy of segmentation, segmentation software breakdown still occur with both time domain
and spectral / Fourier domain OCT devices.27-31 Other OCT artifacts which hinder the accuracy
of thickness analysis may be the result of operator-induced acquisition errors, such as the
shifting of OCT images out of the range of the scan area. Additionally, OCT artifacts may
result from patient motion or eccentric fixation. While segmentation software breakdown may
be manually corrected, it is time consuming, not always practical, and sometimes not feasible
in clinical settings.
This study utilized scans from three commercially available spectral / Fourier domain OCT
instruments and one standard time domain OCT device to evaluate six different types of OCT
scan artifacts in eyes with macular disease. This study also assessed inter-scan reproducibility
and time domain to spectral domain OCT agreeability in pathological states.
Methods
Subjects
Patients seen at the New England Eye Center, Tufts Medical Center between February and
August 2008 who fit the inclusion criteria were invited into this study. Qualified patients were
then enrolled into the study after receiving their informed consent. The study was conducted
in accordance with the ethical standards stated in the 1964 Declaration of Helsinki and approved
by the Institutional Review Board of Tufts Medical Center. Ocular pathologies of eyes in this
study included lamellar or full-thickness macular holes, neovascular and non-neovascular
AMD, posterior vitreous detachment, CNVM, idiopathic juxtafoveal telangiectasia (IJT),
diabetic retinopathy, retinal vascular obstruction, Stargardt disease, ERM, cystoid macular
edema, central serous chorioretinopathy (CSCR), and angioid streaks.
Technology Utilized
In patients with bilateral disease, the eye that was most seriously affected, based on Snellen
visual acuity, was selected as the study eye. Subjects were scanned on a single time domain
OCT device: Stratus OCT (software version 4.0; Carl Zeiss Meditec, Inc., Dublin, CA, USA),
and three spectral / Fourier domain OCT: Cirrus HD-OCT (software version 3.0; Carl Zeiss
Meditec, Inc., Dublin, CA, USA), RTVue-100 (software version 3.5; Optovue, Inc., Fremont,
CA, USA) and Topcon 3D OCT-1000 (software version 2.12; Topcon, Inc., Paramus, NJ,
USA). Subjects were scanned twice on each of the three spectral / Fourier domain devices with
each protocol, having one minute rest between scans (in this study, the term “scan”, if not
otherwise specified, is defined as all images acquired within a given protocol; for example, all
128 raster scans in the Cirrus macular cube 512×128). Scans were obtained on the same day,
by the same operator, and in variable sequence.
The Cirrus HD-OCT has a 5 μm axial image resolution and an imaging speed of 27,000 axial-
scans per second. The RTVue-100 has a 6 μm axial image resolution and a speed of 26,000 A-
scans per second. Topcon 3D-OCT 1000 has a 5 μm axial image resolution and a speed of
18,000 A-scans per second. The Stratus OCT has a 8−10 μm axial resolution and acquires
images at speeds of 400 axial scans per second.
Scan Protocols
Patients were scanned via time domain detection using the Stratus OCT and were imaged only
once per visit. The macular thickness protocol (6 radial, equally-spaced 6 mm scans with 512
A-scans per line) was performed. All scans acquired had a signal strength of at least 5 (out of
10).
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Subjects were scanned via spectral / Fourier domain detection with three different commercial
SD- OCTs. Participants were scanned twice with each protocol per visit:
• The Cirrus HD-OCT scan protocol (∼2.5 seconds) consisted of the macular cube
512×128 scan (with 128 horizontal raster, 512 A-scans per line, in a 6×6 mm area,
resulting in a sample density of ∼47 μm between A-scans in the superior-inferior
direction and ∼12 μm in the temporal-nasal direction). All scans had signal strengths
of at least 5 (out of 10).
• The RTVue-100 scan protocol consisted of MM5 (0.78 seconds; outer 5×5 mm grid
of 11 horizontal and 11 vertical lines of 668 A-scans each spaced 0.5 mm apart and
an inner 3×3 mm grid of 6 horizontal and 6 vertical lines with 400 A-scans each spaced
0.5 mm apart, resulting in the inner 3×3 mm region being sampled with 250 μm
between B-scans and 10 μm between A-scans in each B-scan) or EMM5 (0.90
seconds; outer 6×6 mm grid of 13 horizontal and 13 vertical lines with 668 A-scans
each and an inner 4×4 mm grid of 8 horizontal and 8 vertical lines with 400 A-scans
each, resulting in the inner 4×4 mm region being sampled with 250 μm between B-
scans and 10 μm between A-scans in each B-scan) and MM6 (0.27 seconds; 12 radial
scans with 1,024 A-scans each, with a 6 mm diameter). All scans had signal strengths
of at least 40 (out of 100). Patients imaged from July 2008 onwards were scanned
with EMM5 instead of the MM5 due to the availability of this new scan protocol.
• The Topcon 3D-OCT 1000 scan protocols consisted of the radial scan (0.30 seconds;
6 radial scans with 1024 A-scans each) and 3D macular scan (3.6 seconds; 128 raster
scans with 512 A-scans each, within a 6×6 mm area, resulting in a sample density of
∼47 μm between A-scans in the superior-inferior direction and ∼12 μm in the
temporal-nasal direction.). All scans had signal strengths of at least 40 (out of 100).
Artifacts Classification
Inner/outer retinal layer misidentification—Each of the 9 subfields of the ETDRS- like
map was recorded for all scans taken. The central foveal region was the central 1 mm of the
map. Immediately surrounding the central foveal subfield was the parafoveal region, which
had a diameter of 3 mm. Surrounding the parafoveal region was the perifoveal region (5 mm
diameter).
Subsequently, all images acquired within each scan pattern (for example, 128 raster scans in
Cirrus macular cube 512×128) were reviewed to check for segmentation breakdown in the
inner and outer retinal layers. All devices used the internal limiting membrane for the placement
of the inner retinal layer. For the outer retinal layer: Stratus OCT used the inner segment/ outer
segment (IS/OS) junction, Cirrus HD-OCT and the RTVue-100 used the RPE, and the Topcon
3D-OCT 1000 used the photoreceptor outer segment tip. Figure 1 demonstrates the proper
placement of the outer retina for all devices analyzed in this study. If segmentation algorithm
broke down in the inner retinal layer, it was recorded as inner retina misidentification. If
segmentation broke down in the outer retinal layer, it was recorded as outer retina
misidentification.
Inaccurate foveal thickness—In cases where segmentation breakdown occurred in the
inner or outer retinal layers within the central foveal region (center 1 mm), manual correction
was employed to correct for the segmentation breakdown. Cirrus 512×128 cube scan has a 6×6
mm scan area composed of 128 horizontal B-scans. To determine the number of scans located
in the central foveal region, 128 B-scans were divided into 6 mm to obtain ∼22 B-scans.
Topographic map and OCT B-scans were then used to locate the 22 B-scans centered at the
central foveal region. RTVue MM5 scan has a retinal scan area of 5×5 mm and is composed
of 17 horizontal B-scans, while the EMM5 has a scan area of 6×6 mm with 21 horizontal B-
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scans. A similar approach to the Cirrus was undertaken to obtain a central foveal region of
∼4 B-scans for both RTVue scan patterns and then topographic map and OCT B-scans were
used to locate these scans in the central foveal regions. Topcon 3D scan protocol allowed for
the placement of the EDTRS grid over the topographic map. The central foveal subfield of the
EDTRS grid could be moved over the central foveal region shown on the topographic map and
B-scans could subsequently be analyzed for segmentation breakdown at the central foveal
region.
For spectral / Fourier domain OCT, inner and outer retinal boundary lines were redrawn where
errors occurred to reflect their proper locations by one of the authors (JH). For Stratus OCT,
since there was no way to redraw segmentation lines, OCT images with improper segmentation
line placements were not factored into the retinal thickness calculations and only images with
proper segmentation line placements were included. Changes ≥ 1 μm in the average central
foveal thickness as reported by the software post-manual correction were recorded as an
inaccurate foveal thickness, while changes ≥ 11 μm post-manual corrections within the
central foveal subfield were recorded as clinically significant inaccurate foveal thickness.
This clinically significant cutoff point was established from previously reported results of Chan
et al who found that the average standard deviation of central macular thickness measurements
in normal eyes was 11 μm via a time domain OCT detection.32 This value also matched the
order of the OCT system's axial resolution. Therefore, we selected this value as a conservative
estimate for a significance threshold of clinically significant error in foveal thickness, since
post-manual changes less than this value may not be great enough to warrant correction
clinically, as this variation could occur by chance.
Off-center fixation—An error in fixation was recorded when the central foveal subfield of
the ETDRS-like map was more than 0.25 mm away from the true center based on both the
topographic map and OCT B-scan data. In cases of certain pathologies (for example,
neovascular AMD) where foveal centers were not apparent from topographic information
alone, visual examinations of all acquired raster scans were utilized to estimate their locations.
For RTVue-100 and Topcon 3D-OCT 1000, the ETDRS- like map was moved to where the
central foveal region should be based on the topographic map and raster scan images in cases
of eccentric fixation.
Out of range—Out of range artifacts were identified when OCT images were vertically
shifted, causing a truncated inner or outer retina. Figure 2 presents examples of all the artifact
types analyzed in this study.
Statistical Analysis
Mean thickness, standard deviation and 95% confidence interval for each region of the EDTRS-
like map were computed and their significance was compared across all devices using repeated
measure analysis of variance (ANOVA) [SAS Institute, Cary, NC]. Logs of central foveal
thicknesses (CFTs) for first and second scans (both pre- and post manual adjustment) were
taken and then two-tailed T-tests [Microsoft Excel, Redmond, WA] were conducted to compare
the mean differences between first and second scan CFTs. First scan MM5 and EMM5 CFTs
post log-transformation was also compared using two-tailed T test.
The percent occurrence of any errors, improper CFT (≥1 μm and ≥ 11μm), inner and outer
retina misidentification, out of range error, and off center errors were computed for the first
scan of each device and their significance across all devices was determined by generalized
estimating equations [SAS Institute, Cary, NC]. The absolute value of the change in CFT post-
manual correction was grouped into increasing breakdown thresholds (from 10 μm to 250
μm) by each device and then counted and plotted (Figure 3) [Microsoft Excel, Redmond, WA].
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Additionally, the rate of clinically significant improper foveal thickness occurring in each of
the devices was broken down by diagnosis. Subgroup analysis via generalized estimating
equations was conducted for diseases that yielded the highest number of patients (ERM and
neovascular AMD) in order to compare the relative frequencies of clinically significant
inaccurate foveal thickness occurring among the OCT devices. Percentage of inner and outer
retina misidentification was also calculated for each of the disease states examined grouped
by devices.
Reproducibility of scans was evaluated by computing the intraclass correlation coefficient
(ICC) and 95% confidence interval comparing average first versus second scan foveal thickness
measurements in all subfields. Bland-Altman plots were constructed to assess the level of
agreeability between time domain and each spectral domain OCT device. The Bland-Altman
limits of agreement (95% confidence interval) was also computed.
Results
At the end of the recruitment period, a total of 52 patients were enrolled, including two who
returned to the clinic one month later for repeat scans. The breakdown of retinal pathologies
was as follows: 15 ERM, 13 neovascular AMD, 8 diabetic macular edema and diabetic
retinopathy, 6 non-neovascular AMD, 4 VMT, 4 lamellar or full thickness macular holes, 3
cystoid macular edema, 3 CSCR, 2 retinal vascular obstruction, 1 IJT, 1 Stargardt disease, and
1 angioid streaks. The mean age of the subjects was 67 ± 13 years (with a range from 27 to
92). Gender breakdown consisted of 30 females and 22 males, of whom 49 were Caucasian, 2
were African-American and 1 was Middle Eastern.
Macular thickness
Table 1 showed the mean and standard deviation for each of the foveal subfields in both time-
and spectral / Fourier domain OCT. Standard deviations were all largest at the central foveal
region in both time domain as well as spectral / Fourier domain OCT. Parafoveal regions were
the thickest on average compared to central foveal or perifoveal subfields. T-tests comparing
MM5 to EMM5 scans for each foveal subfield were performed post log-transformation of data
to assess the validity of using the two types of scans interchangeably in analysis. No statistical
difference between scans was found (data not shown). Scans from all three spectral domain
OCT all generated greater CFT compared to Stratus OCT scans post manual correction. Paired
T -tests were conducted after log- transformation of data to compare first versus second scan
CFT and neither pre- nor post-manually adjusted data showed statistical significance. This
analysis was not conducted for the time domain OCT since no repeat scans were done for this
device.
Error rate
Spectral / Fourier domain and time domain OCT both revealed high occurrence of any artifacts
(Table 2), ranging from 68.5% (Cirrus cube scan 512×128) to 90.60% (Topcon 3D). The high
incidences of errors present in these devices was largely due to our strict definition of improper
foveal thickness, where even changes in CFT of 1 μm post-manual adjustment would be
categorized as an incidence of this artifact. Thus while the occurrence of improper foveal
thickness may be high, changes as small as 1 μm post-manual correction would most likely
not be clinically significant, that was why we devised the “clinically significant improper foveal
thickness” artifact category.
While spectral / Fourier domain detection (RTVue (E)MM5) had the highest percent of
improper foveal thicknesses, time domain OCT had the highest percentage of clinically
significant errors (change post- manual correction ≥ 11 μm). Segmentation errors in the inner
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retina was universally greater compared to that for the outer retina across both spectral / Fourier
domain and time domain OCT. Out of range and off center artifacts were among the lowest in
terms of the error incidences. Out of range error was the only artifact category that did not
reach statistical significance (p= 0.177) when compared across OCT devices and off center
artifact was borderline significant (p= 0.047).
Table 3 presents the percent of clinically significant errors (≥11 μm) for each of the commercial
OCT devices broken down by diagnosis. Lamellar/full thickness macular holes caused the
highest percentages of significant errors for Stratus OCT, RTVue (E)MM5 and MM6 and
Topcon Radial. Retinal vascular obstruction and Stargardt disease caused the greatest
percentage of significant error in Cirrus Cube 512×128 and Topcon 3D Macular, respectively.
Neither angioid streaks nor IJT caused any level of significant errors. Subgroup analysis for
neovascular AMD/CNVM and ERM revealed that Cirrus HD-OCT had the lowest percentages
of any type of artifacts for both disease states, although these differences were not statistically
significant (data not shown).
The absolute level of error post manual correction for each of the devices was broken down
by threshold values and plotted (Figure 3). The Cirrus 512×128 cube scan had the lowest
number of errors at a threshold >10 μm, while (E)MM5 had the highest number of errors out
of the six measurement protocols at that threshold. Cirrus 512×128 cube scan also had the most
rapid drop to the lowest level of error, occurring at an error threshold > 50 μm. Stratus OCT
had the second lowest number of errors at a threshold of >10 μm but plateau at the highest
count of errors. RTVue ((E)MM5, MM6) and Topcon scans (3D macular, radial) displayed
similar behavior in the distribution of errors in each of the breakdown thresholds.
Percentage of inner and outer retina misidentification was calculated for each of the disease
states grouped by devices (Table 4). Highest average percentage of outer retina
misidentification across all OCT devices occurred in CSCR (84%), cystoid macular edema
(64%) and neovascular AMD (60%), while highest average percentage of inner retina
misidentification occurred in VMT (95%), ERM (90%) and lamellar/full thickness macular
hole (75%).
Agreeability
Results from Bland-Altman plots assessing agreeability of mean central subfield thickness
between time domain and the three spectral / Fourier domain OCT were shown in Table 5.
Sample plot comparing Cirrus versus Stratus OCT CFT was shown in Figure 4 (remaining
plots not shown). The limits of agreement (95% confidence interval) crossed zero for all scans
and ranged from 309 μm ((E)MM5) to 396 μm (Topcon radial).
Reproducibility
ICC between first and second scans were computed to assess reproducibility for each spectral /
Fourier OCT device (Table 6). All devices demonstrated excellent reproducibility at the central
foveal region, with ICCs above 0.92. The parafoveal and perifoveal regions generally had
greater variability in the ICCs.
Discussion
Error rate
Several studies have previously reported high levels of errors generated with time domain
detection in pathological eyes.27-30 In our study, we found that Stratus OCT created
significantly higher rates of clinically significant errors compared to any of the spectral / Fourier
domain OCT. Although Stratus OCT had the highest number of clinically significant errors—
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the most important error type examined, it did not perform the poorest out of all of the artifact
types analyzed. In fact, Stratus OCT scans had the lowest percentage of outer retina
misidentification (p= 0.005). This finding suggested that while spectral domain technology
may be superior in terms of decreasing the overall number of clinically significant segmentation
errors, differences in technology may not be the only factor in the determination of
segmentation breakdown rates. Other factors such as the quality of the segmentation software
written for the OCT device may in fact play a very important role in determining the incidences
of segmentation errors present for a device. Additionally, it was also surprising that the
instances of inner retina misidentification were greater than that for the outer retina, as the
former was considered easier and more accurate to segment. A possible explanation for this
could be the number of diseases of the vitreo-retinal interface (15 ERM, 4 VMT, 4 lamellar/
full thickness macular hole) present in this study.
Cirrus HD-OCT had the lowest percentage of improper foveal thickness among spectral /
Fourier domain and time domain OCT. The shape of its breakdown threshold graph reflected
this finding: Cirrus started with the lowest number of clinically significant improper foveal
thickness, later dropping down to a minimum point the earliest. Stratus OCT plateau with the
highest number of scans with large changes in central foveal thickness. This may be due to the
mechanism of correction that was available for this device, such that in cases where multiple
scans contain segmentation artifacts, only a few number of scans without errors were used to
extrapolate the foveal thickness.
Out of range artifacts, a largely operator induced error, was the only error that did not reach
statistical significance. This may suggest that the OCT user interfaces examined in this study
were similar in terms of the ease of acquisition. Additionally, operator induced error may not
be the major factor causing the disparity in artifact prevalence seen between these devices. Off
center fixation was largely a patient induced error. Cirrus HD-OCT scans had the lowest
instances of this artifact (p= 0.047). One possible explanation for the low instances of this
artifact may be the improved speed decreasing the instances of fixation drift.
The percentage of inner and outer retina misidentification was broken down across the various
disease states (Table 4) and the results were as expected: in diseases of the vitreo-retinal
interface (such as ERM, VMT, lamellar/full thickness macular hole), the prevalence of inner
retina misidentification were high; in diseases where subretinal fluid were present thus
obscuring the outer retinal boundary (i.e. neovascular AMD and CSCR), the percentage of
outer retinal misidentification were increased.
Reproducibility
Numerous studies confirm the high reproducibility of macular thickness measurements in time
domain OCT.33-37 However, the reproducibility among spectral domain OCT have been less
studied. Leung, et al found that SD-OCT macular thickness measurements demonstrated high
repeatability with ICC ranging from 0.92 to 0.99 using Topcon 3D OCT-1000 in normal eyes.
38 Forooghian, et al also found high reproducibility for SD-OCT using the Cirrus HD-OCT
with ICCs ranging from 0.84 to 1.00 in eyes with clinically significant macular edema.39 This
current study also found high levels of repeatability among spectral domain systems,
particularly in the central foveal region with ICCs ranging from 0.92 (Cirrus and RTVue (E)
MM5) to 0.97 (Topcon Radial). In addition, we found a wider range of ICCs outside of the
central foveal region, most evident perifoveally (where the lowest ICCs could be found across
all scans except for the Topcon 3D protocol). One possible explanation for this observation
may be the presence of eccentric fixation or out of register error, causing scans to get cut off
at the periphery of the scan area, leading to segmentation errors to occur at higher rates in the
perifoveal regions. While reproducibility in peripheral regions may be lower compared to the
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central foveal region, this may not be as clinically significant, since peripheral vision may not
be as significant in central visual acuity measures.
Leung et al suggested that the higher reproducibility observed in spectral / Fourier domain
systems compared to those in time domain OCT may be due to the former's higher scan rate,
which enabled macular mapping with fewer motion artifacts and thus more accurate and
repeatable segmentation. When examining Cirrus macular cube 512×128 versus Topcon 3D
scan, this assertion appeared to agree with our data. While both protocols had the same scan
density and area, different ranges of repeatability were obtained. Cirrus HD-OCT, with its
scanning speed of 27,000 A-scans/second, gave a smaller range in the limits of agreeability or
95% CI (326 μm) and thus higher repeatability. Topcon 3D, with a slower scanning speed of
18,000 A-scans/second, produced a larger range in the limits of agreeability (360 μm).
Forooghian et al proposed that higher scan density may also aid in the reproducibility of scans
since increased sampling points would decrease the level of extrapolation used between points.
Data from Paunescu et al confirmed that high density scanning (512 A-scans/line) led to
significantly higher reproducibility compared to low density scans (128 A-scans/line) on
Stratus OCT.33 RTVue MM6 scan pattern consisted of 12 radial scans with 1,024 A-scans/line
within a 6 mm diameter circle while Topcon radial scan consisted of 6 radial scans also with
the same A-scans/line within the same size circle. Given the specifications, RTVue MM6 had
a denser scan pattern compared to Topcon radial scan and the range for the limits of agreement
between the two scans did seem to reflect this difference (319 μm for MM6 and 396 μm for
Topcon radial). It was unclear in this comparison how much the higher scanning speed of the
RTVue over the Topcon contributed to the former's higher reproducibility (as opposed to the
increased scan density), but we speculate that both factors played roles in their relative
reproducibility.
Although higher density scanning may compromise scanning speed, and vice versa, it appeared
that both improved scanning speed as well as increased scanning density may play roles in
improving reproducibility of scans in spectral / Fourier domain OCT.
Agreeability
Bland-Altman plots and their limits of agreement (95% confidence interval) were computed
to assess agreeability between time domain and each spectral / Fourier systems. The range of
agreement was broad, from 309 μm (Stratus OCT versus (E)MM5) to 396 μm (Topcon Radial).
With such poor agreement, thickness measurements obtained from time domain systems could
not be directly compared to spectral /Fourier domain OCT. Our results were in accordance to
Leung and Forooghian, whose largest ranges for limits of agreement were 38.6 μm and 168
μm, respectively. The relative ranges obtained from their papers was not unexpected, as the
first study was conducted in normal patients and the latter study in patients with clinically
significant diabetic macular edema. The present study was conducted in patients with a wide
range of retinal pathologies, which may be the reason why the limits of agreement were even
wider. A possible way to improve agreeability and thus increase the direct comparability among
commercial OCT devices might be to standardize the boundary of the outer retina to a specific
location. In this study, the least amount of outer retinal breakdown occurred with the Stratus
OCT, which segmented the outer border at the IS/OS junction and so this may appear to be a
location of interest for future development of segmentation software. However, when the level
of outer retinal breakdown was separated out by diseases, it increased substantially in diseases
where the outer retinal boundary becomes obscured, such as neovascular AMD. In fact, Topcon
radial (23% breakdown), Cirrus (54%), and (E)MM5 (60%) scans all performed better
compared to Stratus OCT (67%) in segmentation of the outer retina in this example.
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Macular Thickness
Like Leung and Forooghian, we also found significantly different macular thickness
measurements between time domain and spectral domain systems. Both groups found higher
thickness measurements in spectral domain OCT compared to time domain OCT. We also
arrived at the same conclusion for post-correction thickness for all three SD- OCT. This was
not surprising since the boundary for the outer retina was set at the RPE for Cirrus and RTVue
and at the photoreceptor outer segment tip for the Topcon, while the boundary was set at the
IS/OS for the Stratus OCT. Since there was no agreement in the macular thicknesses obtained
from each of the spectral / Fourier domain devices, future work will need to be conducted to
find the normal macular thickness for each device. Doing this may aid in the standardization
of macular thicknesses across the various spectral / Fourier domain OCT.
The standard deviation for the central foveal region was larger than in any other regions for all
scan protocols, this was likely due to the foveal depression causing greater variability in the
distance between the inner and the outer retina.
Limitations
There were several limitations to this study. First, three experienced operators were used to
acquire the OCT images (JH, ACS, LNV). Although the spectral / Fourier domain OCT
examined in this study all had registration features which may already decrease intra-patient
variability, as an additional precaution, the same operator conducted both the first and the repeat
scans for each patient. Additionally, a minority of the patients scanned were not dilated. Small
pupils may affect scan quality in patients. Patients were scanned only once on the Stratus OCT,
as a part of the baseline examination in this group. Thus the reproducibility of Stratus OCT in
diseased eyes could not be obtained. Lastly, while this study examined eyes across a broad
spectrum of retinal disorders, note that results obtained from this study can only be generalized
to this subset of patients. Since some of the disease categories had small number of patients
within them, we were not able to compare error rates across the various devices for these
pathologies in sub group analysis.
This was the first study, to our knowledge to compare the reproducibility, agreeability, and
error rates among the various spectral / Fourier OCT in eyes with a wide range of underlying
retinal pathologies. Cirrus HD-OCT scans exhibited the lowest occurrence of any artifacts
(68.5%), improper foveal thickness (40.7%; ≥ 1 μm change post-manual correction) and
clinically significant improper foveal thickness (11.1%; ≥ 11 μm change post-manual
correction) compared to the other OCT devices examined in this study. Stratus OCT scans
exhibited the highest occurrence of clinically significant improper foveal thickness compared
to all 3 spectral domain OCT analyzed. All spectral / Fourier domain OCT examined in this
study revealed high levels of reproducibility, especially in the central foveal subfield (with
ICCs all above 0.92). Significant differences in macular thickness existed between the various
spectral / Fourier domain OCT examined and with the Stratus OCT. Higher scan density and
speed may improve reproducibility of OCT scans. Although the rates of any artifacts vary
across commercial OCT, ranging from 68.5 % (Cirrus 512×128 cube) to 90.6% (Topcon 3D
scan), these rates were large enough to warrant improvement in segmentation algorithm to
decrease future incidences of these artifacts.
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Figure 1 A-D.
Location of Optical Coherence Tomography (OCT) inner and outer retinal layer segmentation.
Time domain and spectral / Fourier domain OCT all segments inner retina at the internal
limiting membrane (ILM). In terms of outer retinal layer segmentation: (A) Stratus OCT
segments at the inner segment/outer segment (IS/OS) junction,
(B) Cirrus HD-OCT and (C) RTVue-100 both segment at the retinal pigment epithelium (RPE),
(D) Topcon 3D OCT-1000 segments at the photoreceptor outer segment tips.
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Figure 2 A-D.
Demonstration of Artifact Types:
(A) Inner retina misidentification: notice the light blue segmentation line followed the
epiretinal membrane;
(B) outer retina misidentification: the dark blue segmentation line does not follow the contour
of the retinal pigment epithelium (RPE);
(C) out of register: the RPE is shifted inferiorly thus cut out of frame causing an error in the
outer retina segmentation line (in dark blue);
(D) off center fixation: notice the central foveal region which is delineated in blue via the
topographic map is outside the central circle.
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Figure 3.
Breakdown threshold graph. The absolute values of improper foveal thicknesses (in μm) are
group by different thresholds of breakdown and counted for each device. Cirrus= Cirrus
macular cube 512×128, (E)MM5= RTVue (E)MM5, MM6= RTVue MM6, Top 3D= Topcon
3D macular, Top Rad= Topcon Radial, Stratus= Stratus macular thickness protocol.
Ho et al. Page 15
Ophthalmology. Author manuscript; available in PMC 2010 October 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 4.
Bland-Altman plot for central subfield thickness comparing Stratus OCT to Cirrus HD-OCT,
shown as average of Cirrus HD-OCT and Stratus OCT (x- axis, in μm) versus the difference
between thicknesses obtained from the two devices (y- axis, in μm). CFT= Central foveal
thickness.
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Table 5
Bland-Altman Plot Summary.
Central Subfield Mean ± SD Mean Difference (Stratus-SD
OCT)
Bland-Altman Limits of
Agreement (95% CI)
Range (in μm)
Cirrus Mac Cube 512×128* 340±109 −12 (−184, 142) 326
RTVue (E)MM5 360±109 −32 (−193, 116) 309
RTVue MM6 339±105 −11 (−179, 140) 319
Topcon 3D 313±123 15 (−180, 180) 360
Topcon Radial 310±126 18 (−193, 203) 396
Central foveal thicknesses (μm) in Stratus OCT is compared to each spectral domain Optical Coherence Tomography device. Bland-Altman limits of
agreement and range of 95% confidence interval are also displayed (both in μm). SD= standard deviation, CI= confidence interval.
*
Example of Bland-Altman plot is shown in Figure 4.
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